NXL — Nexalin Technology Share News
0.000.00%
- $2.03m
- $1.03m
- $0.30m
Brief: Nexalin Technology, Inc. And Wider Come Limited Announce Joint Venture Agreement To Advance Commercialization Of Nexalin’S Tacs Devices In The Asia Pacific Region
Brief: Nexalin Technology Says On May 10, Got Notice From Nasdaq That Co No Longer Complies With Minimum Bid Price Requirement For Continued Listing
Brief: Nexalin Technology Provides 2022 Year-End Business Update
Brief: Nexalin Technology Plans To Present GEN-2 And GEN-3 To FDA For Treatment Of Anxiety And Insomnia
Brief: Nexalin Technology, Inc. Announces Pricing Of $9.6 Million IPO